Pharmaceuticals, Biotechnology and Life Sciences
WOBURN, Mass.–(BUSINESS WIRE)–CutisPharma, Inc. announced today its acquisition of Silvergate Pharmaceuticals, Inc. and the unveiling of its new corporate brand…
Share subscription agreement of 4.1million AUD with Microba Microbiome database construction in Asia Pacific region within the year, followed by…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Syros Pharmaceuticals (NASDAQ: SYRS), a biopharmaceutical company pioneering the development of medicines to control the expression of genes,…
Genetic testing to enable improved patient diagnoses and provide valuable disease-specific genetic insights for X4 clinical development of novel therapies…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, today announced…
BRISBANE, Calif.–(BUSINESS WIRE)–Aimmune Therapeutics, Inc. (Nasdaq: AIMT), a biopharmaceutical company developing treatments for life-threatening food allergies, today announced that its President…
Results to be Presented During a Late-Breaking Oral Session at the Annual European Congress of Rheumatology (EULAR 2019) NEW YORK–(BUSINESS…
– Advances lead product into clinic and additional compounds into preclinical development – David Mauro, MD, PhD, as Chief Medical…
-Data Presentations Highlight Continued Advances in Research for Treating Blood Cancers- BOTHELL, Wash.–(BUSINESS WIRE)–Seattle Genetics, Inc. (Nasdaq:SGEN) today announced data…
– CureRareDisease.org brings together researchers and clinicians to develop customized therapeutics applied to Duchenne Muscular Dystrophy and other rare diseases…